Drugs / Polytrim
Regulatory milestones approvals, filings & regulatory actions · 1 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Approved | US (FDA) | POLYTRIM | — | 1988-10-20 | fda.gov ↗ |
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy2 trials | ||||||
| Phase 1 | NCT01431170 Comparator | Sep 2011 → Jun 2014 | lacrimal duct obstruction | Rutgers, The State University of New Jersey | Completed | No outcome recorded |
| Phase 4 | NCT00581542 Comparator | Mar 2007 → Mar 2009 | conjunctivitis | University of Rochester | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Polytrim | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01431170 ↗ |
| Route | Other | “Polytrim Ophthalmic Solution” NCT00581542 ↗ |